This activity is provided by Forefront Collaborative.
This activity is supported by an educational grant from Exact Sciences.
Controversy or conundrum? New guidelines on early colorectal cancer (CRC) screening are stirring debate, with different viewpoints on when to initiate testing and what methods to use. Through interactive presentations and case studies, attendees can cut through the confusion to better understand how to translate guidelines to direct individualized clinical decision making. This endured webcast consists of a video recording of the faculty presenting at a live symposium (in conjunction with the American College of Gastroenterology [ACG] 2018 Annual Scientific Meeting) synchronized to the slide presentation and audio. The symposium is delivered by three gastroenterologists with expertise in CRC screening and screening guidelines, with one presentation including a review of cases to walk learners through clinical decision-making when screening for CRC. Polling questions in each of the live presentations served as a jumping-off point for further faculty discussion.
The target audience for this educational activity is gastroenterologists. Primary care physicians and other clinicians in a position to detect colorectal cancer early may benefit from participation in this educational activity.
Upon completion of the activity, participants should be able to:
Describe the epidemiology of colorectal cancer
Discuss USPSTF, MSTF, and ACS guidelines for colorectal cancer screening
Analyze advantages and disadvantages for various screening methods
Develop screening plans depending on patient features
There is no fee for this educational activity.
Conflict Of Interest Disclosure Policy
Educational activities provided by Forefront Collaborative must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s)*. For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias. Disclosures appear below.
*The ACCME defines a commercial interest as any entity producing, marketing, reselling, or distributing healthcare goods or services consumed by or used on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Brooks D. Cash, MD—Activity Chair Chief, Division of Gastroenterology, Hepatology, and Nutrition Co-Director, Ertan Digestive Disease Center Visiting Professor of Medicine McGovern Medical School University of Texas Health Science Center at Houston Houston, Texas
Dr. Cash, MD discloses the following: Consultant: Exact Sciences
Deborah A. Fisher, MD, MHS Associate Professor of Medicine Division of Gastroenterology Duke University Associate Director, Gastroenterology Research Duke Clinical Research Institute Durham, North Carolina
Dr. Fisher discloses the following: Grant/Research support: Epigenomics
Douglas J. Robertson, MD, MPH Professor of Medicine Geisel School of Medicine at Dartmouth & The Dartmouth Institute for Health Policy & Clinical Practice Hanover, New Hampshire Chief, Gastroenterology White River Junction VA Medical Center White River Junction, Vermont
Dr. Robertson Consultant: Freenome
Accredited Provider Disclosure
Maria Rovere, MTSC, has nothing to disclose in regards to financial relationship(s) with commercial interests. Jessica Porucznik has nothing to disclose in regards to financial relationship(s) with commercial interests. Lilia Zurkovsky, PhD, has nothing to disclose in regards to financial relationship(s) with commercial interests.
AMA PRA Category 1 Credit(s)TM
Forefront Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Forefront Collaborative designates this live activity for a maximum of 1.50 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This continuing medical education activity may include reference(s) to unlabeled or unapproved uses of drugs.
The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views or recommendations of Forefront Collaborative or Exact Sciences.
The content of this activity was independently peer reviewed by two reviewers. The reviewers of this activity have no relevant financial relationships to disclose.
To obtain credit, a score of 80% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.